Ekso Bionics Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Ekso Bionics Stock Summary

Ekso Bionics competes with Pro Dex, Coloplast, Straumann Holding, Nephros, and InfuSystems Holdings. Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. The company was incorporated in 2005 and is headquartered in Richmond, California. Ekso Bionics operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 55 people.

Ekso Bionics Key Financial Ratios

Ekso Bionics Key Balance Sheet Accounts

Ekso Bionics Key Income Statement Accounts

Ekso Bionics Key Cash Accounts

Ekso Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Ekso Bionics's current stock value. Our valuation model uses many indicators to compare Ekso Bionics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Ekso Bionics competition to find correlations between indicators driving Ekso Bionics's intrinsic value. More Info.Ekso Bionics Holdings is rated # 5 in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Ekso Bionics' Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Ekso Bionics' earnings, one of the primary drivers of an investment's value.

Ekso Bionics Holdings Systematic Risk

Today, most investors in Ekso Bionics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Ekso Bionics' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Ekso Bionics growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Ekso Bionics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Ekso Bionics Holdings. We use our internally-developed statistical techniques to arrive at the intrinsic value of Ekso Bionics Holdings based on widely used predictive technical indicators. In general, we focus on analyzing Ekso Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Ekso Bionics's daily price indicators and compare them against related drivers.

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Ekso Bionics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ekso Bionics. If investors know Ekso will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ekso Bionics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Ekso Bionics Holdings is measured differently than its book value, which is the value of Ekso that is recorded on the company's balance sheet. Investors also form their own opinion of Ekso Bionics' value that differs from its market value or its book value, called intrinsic value, which is Ekso Bionics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ekso Bionics' market value can be influenced by many factors that don't directly affect Ekso Bionics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Ekso Bionics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ekso Bionics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ekso Bionics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.